Among histological aggressive non-Hodgkin lymphomas (NHL), the overall risk of central nervous system (CNS) relapse is approximately 5%, a figure which is too low to offer prophylaxis to all patients. The aim of this work is to demonstrate the utility of flow cytometry (FCM) in detecting occult lept
Identification of Leptomeningeal Disease in Aggressive B-Cell Non-Hodgkin's Lymphoma: Improved Sensitivity of Flow Cytometry
β Scribed by Quijano, S.; Lopez, A.; Manuel Sancho, J.; Panizo, C.; Deben, G.; Castilla, C.; Antonio Garcia-Vela, J.; Salar, A.; Alonso-Vence, N.; Gonzalez-Barca, E.; Penalver, F. J.; Plaza-Villa, J.; Morado, M.; Garcia-Marco, J.; Arias, J.; Briones, J.; Ferrer, S.; Capote, J.; Nicolas, C.; Orfao, A.
- Book ID
- 121856489
- Publisher
- American Society of Clinical Oncology
- Year
- 2009
- Tongue
- English
- Weight
- 182 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0732-183X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The prognostic relevance of flow cytometric DNA measurements of lymph node biopsies in relation to histopathology according to the Kiel classification, stage, age and presence or absence of B-symptoms was investigated in 106 patients with non-Hodgkin lymphomas (NHL) of proven B-cell type. Biopsies w
The aim of this study was to analyse dynamic cell proliferation parameters in non-Hodgkin's lymphomas. Sixty-one patients with newly diagnosed or with recurrent disease were given iododeoxyuridine (IdUrd) intravenously near 4 h prior to tumour biopsy. After staining with an IdUrd reactive antibody a